Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2381-2400 of 3,190 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

TERMINATEDPhase 2< 1 mile

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

NCT01836549

This molecular biology and phase II trial studies how well imetelstat sodium works in treating younger patients with recurrent or refractory brain tumors. Imetelstat sodium may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Anaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more

Pediatric Brain Tumor Consortium43 participantsStarted Mar 2013

Los Angeles, California, United States • Palo Alto, California, United States • Washington D.C., District of Columbia, United States +8 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Rheumatoid Arthritis Trials in Other Cities

Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

An Open Label Study for Participants With Rheumatoid Arthritis

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

OLIF25™ /OLIF51™ Study

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Other Conditions in Los Angeles